|
Eyenovia inc (NASDAQ: EYEN) |
|
Eyenovia inc
EYEN's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Eyenovia Inc growth rates, revenue grew
by 985.09 % in the fourth quarter of 2024 from the same quarter a year ago.
Ranking at No. 1983
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.85 %
Eyenovia Inc net loss increased from $-8 millions, to $-20 millions in fourth quarter of 2024,
• More on EYEN's Growth
|
|
Eyenovia Inc realized a net loss in trailing twelve months.
Eyenovia Inc realized cash reduction of $ -15.28 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 17.14.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.03.
• More on EYEN's Valuation
|
|
|
|
|
Eyenovia Inc realized net loss in trailing twelve months.
Eyenovia Inc realized cash outflow of $ -15.28per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 17.14.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.03.
• More on EYEN's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com